Navigating an executive leadership change? Use our eBook to facilitate a smooth transition. Download Now

Westicke Partners

Close

ICR Westwicke Blog

The ICR Westwicke Blog is designed to deliver information and insights into the ever-changing world of healthcare communications.

The ‘Innovator’s Burden’: How to combat skepticism in healthcare as a first-of-its-kind company

Posted on September 26th, 2022. Posted by

Close up on gloved hand holding vile of liquid under microscope

From new treatments and technologies to platforms and diagnostics, we may be living through the greatest period of innovation in the history of healthcare. The biopharma industry’s efforts to rapidly develop multiple safe and efficacious life-saving vaccines for the Covid-19 pandemic is just the latest example of the collective appreciation for innovation and its ability to impact human health. While the industry loves true innovations—and the brilliant minds who envision them—being an innovator is not for the faint of heart.

Continue Reading

Biotech Investor Relations: Six Burning Questions Answered

Posted on July 11th, 2022. Posted by

Biotech Investor Relations: Six Burning Questions Answered

I have always found it interesting to discover what’s on people’s minds and delve into what keeps them up at night. So, I thought it would be useful to share the questions I have received recently from a mix of public and private biotech management teams, along with my responses.

Continue Reading

The Perfect Earnings Call: Your 5-Week Prep Plan

Posted on March 29th, 2022. Posted by

Over the last 25 years, I have listened to hundreds of earnings calls. As a sell-side analyst, they were a routine and not-much-fun part of the job. Four times a year, you lock yourself in your office and listen to call after call of management teams highlighting their achievements or trying to sugar coat the not-so-positive news.

Most of the calls were pretty standard, and came off as well thought-out and comprehensive. But every so often you would hear that call where the sell-side analysts were unforgiving in their questions and the tone was so negative you almost feel bad for the management team. In my role here at ICR Westwicke, I’ve learned what really goes on behind the scenes to make those effective earnings calls appear effortless: a lot of hard work and practice starting about a month ahead of time. Who would have ever thought?

Continue Reading

The 7 Key Aspects of Investor Relations

Posted on March 28th, 2022. Posted by

Creating an investor relations strategy is no small task — but it’s a critical step for any public company. To meet the expectations of investors and analysts, company leaders must develop a strategic approach for messaging, earnings calls, guidance, conferences, investor interactions and more. While that can seem overwhelming, an effective IR process actually boils down to just seven essential elements. With a plan for each of these areas, you can build a quality, long-term shareholder base and enhance equity market value. 

Continue Reading

6 Commonly Asked Questions (and Answers) About Quiet Periods

Posted on February 21st, 2022. Posted by

Commonly Asked Questions About Quiet Periods

Public healthcare companies often question the best course of action during quiet periods – those stretches of time during which they should limit their interaction with Wall Street due to their knowledge of material and timely information that has not yet been disclosed. Specifically, management teams struggle to figure out what the quiet period means for their investor relations (IR) efforts.

Continue Reading

Bringing Investor Relations and Public Relations Together

Posted on February 9th, 2022. Posted by

IR and PR

If your company is publicly traded or a private company preparing for an IPO, then you likely have two separate communication tasks, one focused on reaching investors and financial analysts, the other on reaching customers and the general public – investor relations and public relations.

Continue Reading

10 Ways to Boost the Effectiveness of Your Biotech Investor Plan

Posted on December 21st, 2021. Posted by

African American boss with employees sitting at desk in boardroom, businesswoman with colleagues discussing business strategy or project together, using laptops, brainstorm or company meeting

Investors know that biotech and biopharma companies in the early development stages can be risky investments. So finding the right investors that believe the rewards will outweigh the risks requires strategy.

Continue Reading

10 Ways to Prep for the J.P. Morgan Healthcare Conference

Posted on December 6th, 2021. Posted by

10 Ways to Prep for the J.P. Morgan Healthcare Conference

Each year, the J.P. Morgan Healthcare Conference provides a critical opportunity to meet with analysts, investors, and other leaders in the healthcare industry. However, making the most of the conference takes preparation.

Continue Reading

Tailor Your Investor Meetings to the Audience and Timeframe

Posted on November 10th, 2021. Posted by

You spend considerable time creating a professional investor presentation that tells a comprehensive story of your company. Yet aside from the analyst/investor due diligence meeting, few opportunities exist for you to deliver the entire presentation from start-to-finish. How, then, can you tailor your presentation to the time and opportunities at hand?

Continue Reading

4 Benefits of Conducting a Perception Audit

Posted on October 20th, 2021. Posted by

Full,Length,Portrait,Of,Business,Team,Stand,Near,The,Window

Do you know how the investment community views your company, including your products, leadership team, business strategy, and financial performance? Asking the tough questions and opening your company up to potential negative feedback can be a scary prospect, but it’s well worth it. By conducting a perception audit — an independent investigation into investor and analyst impressions of a company — your company can realize the following benefits. 

Continue Reading

1 2 3 19

Have News to Release?

Find out whether you should file a Form 8-K, issue a press release, or do both by using our easy-to-reference chart, “Form 8K vs. Press Release: What’s the Difference?

Our Locations